Accrued Expenses

12 Months Ended

Dec. 31, 2023

Accrued Expenses

Accrued Expenses

Note 4.Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	December 31,
	2023		2022
Clinical trial expenses	$	1,993,784	$	1,884,117
Other		424,218		423,629
Total	$	2,418,002	$	2,307,746